0       0


Liver Disease and Nutrition


Mar 19, 2009 12:00am ‐ Mar 19, 2009 12:00am


Credits: None available.

Standard: $49.00
Members: $29.00

Description

The prevalence of obesity continues to rise at a staggering pace as does the incidence of numerous health conditions. Nonalcoholic fatty liver disease (NAFLD) is one of the adverse consequences to the rise in obesity and is becoming a common problem health care professionals must treat. NAFLD is the most prevalent liver disease in the United States, representing an estimated 24% of cases of liver disease. A small percentage of these patients will progress to nonalcoholic steatohepatitis (NASH) and subsequent cirrhosis if medical and nutritional interventions are not implemented. Cirrhosis is a chronic disease of the liver often preceded by hepatitis and fatty liver, independent of the cause. Diagnosing malnutrition in cirrhotic patients is challenging. Tune in as our experts will discuss NAFLD and cirrhosis including risk factors, diagnosis, disease progression, and the role of diet management and specialized nutrition support.

Speaker(s):

Speaker(s):

  • Roger D. Soloway, MD, AGAF, University of Texas Medical Branch
  • Anne M. Tucker, PharmD, BCNSP, Clinical Pharmacy Specialist - Critical Care/Nutrition Support, Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content